Skin color is associated with insulin resistance in nondiabetic peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 29, Issue 4, 2009, Pages 458-464

  Chen, Hung Yuan ^a,b   Kao, Tze Wah ^b   Chiu, Yen Lin ^a,b   Huang, Jenq Wen ^b   Lai, Chun Fai ^a,b   Tsai, Tsen Fang ^b   Chu, Tzong Shinn ^b   Wu, Kwan Dun ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adiponectin; HOMAIR; Insulin resistance; Skin color

Indexed keywords

ADIPONECTIN; ASCORBIC ACID; ERYTHROPOIETIN; GLOBIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SKIN COLOR; VITAMIN SUPPLEMENTATION;

EID: 70349498730     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900413     Document Type: Article

References (31)

1. Abdelbaqi-Salhab M, Shalhub S, Morgan MB. A current review of the cutaneous manifestations of renal disease. J Cutan Pathol 2003; 30:527-38.
2. Lai CF, Kao TW, Tsai TF, Chen HY, Huang KC, Wu MS, et al. Quantitative comparison of skin colors in patients with ESRD undergoing different dialysis modalities. Am J Kidney Dis 2006; 48:292-300.
3. Weatherall IL, Coombs BD. Skin color measurements in terms of CIELAB color space values. J Invest Dermatol 1992; 99:468-73.
4. Smith AG, Shuster S, Thody AJ, Alvarez-Ude F, Kerr DN. Role of the kidney in regulating plasma immunoreactive beta-melanocyte-stimulating hormone. Br Med J 1976; 1:874-6.
5. Takiwaki H. Measurement of skin color: practical application and theoretical considerations. J Med Invest 1998; 44:121-6.
6. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334:374-81.
7. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 2002; 13:1894-900.
8. Scuteri A, Najjar SS, Morrell CH, Lakatta EG. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: The Cardiovascular Health Study. Diabetes Care 2005; 28:882-7.
9. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288:2709-16.
10. Desouza CV, Gerety M, Hamel FG. Neointimal hyperplasia and vascular endothelial growth factor expression are increased in normoglycemic, insulin resistant, obese fatty rats. Atherosclerosis 2006; 184:283-9.
11. de Jongh RT, Serne EH, Ijzerman RG, de Vries G, Stehouwer CD. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004; 109: 2529-35.
12. Meerwaldt R, Links TP, Graaff R, Hoogenberg K, Lefrandt JD, Baynes JW, et al. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 2005; 48:1637-44.
13. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004; 47:1324-30.
14. Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC, et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16:3687-93.
15. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
16. Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC. Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 2004; 79:31-9.
17. Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Zhang H, et al. Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men. Atherosclerosis 2006; 188:184-9.
18. Deleixhe-Mauhin F, Krezinski JM, Rorive G, Pierard GE. Quantification of skin color in patients undergoing maintenance hemodialysis. J Am Acad Dermatol 1992; 27: 950-3.
19. Choi HK, Thome FS, Orlandini T, Barros E. [Increased skin pigmentation in patients with chronic renal failure undergoing hemodialysis infected with the hepatitis C virus]. Rev Assoc Med Bras 2003; 49:24-8.
20. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334:952-7.
21. Sigaudo-Roussel D, Demiot C, Fromy B, Koitka A, Leftheriotis G, Abraham P, et al. Early endothelial dysfunction severely impairs skin blood flow response to local pressure application in streptozotocin-induced diabetic mice. Diabetes 2004; 53:1564-9.
22. Sivitz WI, Wayson SM, Bayless ML, Sinkey CA, Haynes WG. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes. J Diabet Complications 2007; 21:149-57.
23. Quattrini C, Harris ND, Malik RA, Tesfaye S. Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care 2007; 30:655-9.
24. Shoji T, Emoto M, Nishizawa Y. HOMA index to assess insulin resistance in renal failure patients. Nephron 2001; 89: 348-9.
25. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 2004; 43:1047-55.
26. Tigno XT, Selaru IK, Angeloni SV, Hansen BC. Is microvascular flow rate related to ghrelin, leptin and adiponectin levels? Clin Hemorheol Microcirc 2003; 29:409-16.
27. Takano H, Kodama Y, Kitta Y, Nakamura T, Obata JE, Mende A, et al. Transcardiac adiponectin gradient is independently related to endothelial vasomotor function in large and resistance coronary arteries in humans. Am J Physiol Heart Circ Physiol 2006; 291:H2641-H2646.
28. Cheng SC, Chu TS, Huang KY, Chen YM, Chang WK, Tsai TJ, et al. Association of hypertriglyceridemia and insulin resistance in uremic patients undergoing CAPD. Perit Dial Int 2001; 21:282-9.
29. Lee BC, Shore AC, Humphreys JM, Lowe GD, Rumley A, Clark PM, et al. Skin microvascular vasodilatory capacity in offspring of two parents with type 2 diabetes. Diabet Med 2001; 18:541-5.
30. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999; 48:1856-62.
31. Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol 2004; 5:199-203.